Caixin
Caixin Global – Latest China News & Headlines

Home >

ABOUT US

CX Tech is Caixin Global's real-time tech news portal, featuring 24-hour news, short-form analysis, and roundups from business and tech media in China.

LATEST
Trending in China: Medical Drama Salutes Pandemic Heroes but Stirs Sexism Debate
Trending in China – Can Universities Stop Students Wasting Food And Keep Them Happy?
Alibaba Unveils Delivery Robot to Meet ‘Last-Mile’ Demand
Alibaba Launches Palm-Sized Cloud Computer With ‘Almost Unlimited Computing Resources’
China’s National Science Academy Vows to Close Tech Gaps in 10 Years
Trump’s WeChat Ban May Face Temporary Halt by U.S. Judge
Tencent Clinches Deal to Show England’s Premier League in China
Alibaba Unveils ‘Digital Factory’ as Part of Its ‘New Manufacturing’ Strategy
Trending in China: Basketballer Jeremy Lin - Dream Chaser or Delusional? Netizens Divided as Star Leaves CBA for NBA
Trending in China – The Case of the ‘Missing’ iPhone12
Kuaishou Logs 500 Million Online Shopping Orders in August
U.S.-Listed Chinese Delivery Firm ZTO Express Plans to Raise Up to $1.6 Billion in Hong Kong Secondary Listing
Xiaomi Vice Chairman Promises Not Sell More Stock After Selling Over $1 Billion in Company Shares
Autohome Plans $1 Billion Hong Kong Second Listing
Video Streamer iQiyi Kicks Up Its Sports Game with FC Barcelona Tie-Up
Global First as Potential Nasal Spray Covid-19 Vaccine Proceeds to Clinical Trial Phase
JD.com’s Fintech Unit Plans to Spend $230 Million to Get Second Payment License
Trending in China – A Fight Over Steamed Buns Causes Netizens to Ask Whether Traditional Brands Can Survive in the Modern Era
Loss Making Evergrande’s Electric Vehicle Subsidiary to Raise $516 Million from Investors Including Tencent
Kai-Fu Lee’s Remarks Set Off Firestorm Over Facial Recognition
One Year Later, China’s ‘Quieter Outbreak’ Still Plays Out in Thousands of Lives

By Yang Ge / Sep 14, 2020 05:57 PM / Society & Culture

Photo: IC

Photo: IC

Months before the global pandemic started in the central Chinese city of Wuhan at the end of last year, thousands of residents near a biopharmaceutical plant in the Northwestern city of Lanzhou were exposed to the highly contagious and hard-to-treat disease called brucellosis from contaminated exhaust at a biopharmaceutical factory.

Most of those tested positive for antibodies of the disease, which commonly occurs among sheep, cattle, goats, pigs and dogs and also is called Malta Fever or Mediterranean Fever. But few were ever formally diagnosed.

There are more than 10 residential communities with a combined population of more than 10,000 located within 1 kilometer of the plant, and Caixin learned that antibody tests later showed that more than 3,000 were infected.

One of the victims, 40-year-old shopkeeper Gao Hong, a pseudonym, was hit with crippling joint pain and persistent fever. It took nearly six months for doctors to diagnose her condition. By then, she had missed the window for the most effective treatment, leaving her with a hard-to-cure chronic condition that requires long-term medication.

The nightmare for Gao and others started at the Lanzhou Biopharmaceutical Plant, a unit of state-owned China Animal Husbandry Industry Co. Ltd. located on the northeastern periphery of Lanzhou, the capital of Gansu province. Local health authorities later determined the factory used expired sanitizers while producing Brucella vaccines between July 24 and Aug. 20, allowing bacteria to enter the factory’s exhaust and infect people nearby.

To read Caixin’s in-depth, investigative story on this quieter outbreak that has affected thousands of lives, click here.

Contact reporter Yang Ge (geyang@caixin.com)


Share this article
Open WeChat and scan the QR code